Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 31

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 2170-2178

  Tsunoda, Kazuyuki ^a   Ota, Takayuki ^a   Aoki, Miyo ^a   Yamada, Taketo ^a   Nagai, Tetsuo ^a   Nakagawa, Taneaki ^a   Koyasu, Shigeo ^a   Nishikawa, Takeji ^a   Amagai, Masayuki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM; DESMOGLEIN 3; EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ADOLESCENT; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; ASCITES; AUTOIMMUNE DISEASE; BLISTER; BULLOUS SKIN DISEASE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; EPITOPE MAPPING; HISTOPATHOLOGY; HYBRIDOMA; MOLECULAR INTERACTION; MOUSE; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENICITY; PEMPHIGUS VULGARIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL;

EID: 0037442123     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.2170     Document Type: Article

References (43)

1. Stanley, J. R. 1993. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv. Immunol. 53:291.
2. Amagai, M., V. Klaus-Kovtun, and J. R. Stanley. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869.
3. Koch, P. J., and W. W. Franke. 1994. Desmosomal cadherins: another growing multigene family of adhesion molecules. Curr. Opin. Cell Biol. 6:682.
4. Amagai, M. 1995. Adhesion molecules. I. Keratinocyte-keratinocyte interactions, cadherins and pemphigus. J. Invest. Dermatol. 104:146.
5. Anhalt, G. J., R. S. Labib, J. J. Voorhees, T. F. Beals, and L. A, Diaz, 1982. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306:1189.
6. Amagai, M., S. Karpati, R. Prussick, V. Klaus-Kovtun, and J. R. Stanley. 1992. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J. Clin. Invest. 90:919.
7. Amagai. M., T. Nishikawa, H. C. Nousari, G. J. Anhalt, and T. Hashimoto. 1998. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause aeantholysis in vivo in neonatal mice. J. Clin. Invest. 102:775.
8. Amagai, M., T. Hashimoto, N. Shimizu, and T. Nishikawa. 1994. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J. Clin. Invest. 94:59.
9. Sams, W. M. J., and R. E. Jordon. 1971. Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br. J. Dermatol. 84:7.
10. Ishii, K., M. Amagai, R. P. Hall, T. Hashimoto, A. Takayanagi, S. Gamou. N. Shimizu. and T. Nishikawa, 1997. Characterization of autoantibodies in pemphigus using antigen- specific ELISAs with baculovirus expressed recombinant desmogleins. J. Immunol. 159:2010.
11. Amagai, M., A. Komai, T. Hashimoto, Y. Shirakata, K. Hashimoto, T. Yamada, Y. Kitajima, K. Ohya, H. Iwanami. and T. Nishikawa. 1999. Usefulness of enzyme-linked immunosorbent assay (ELISA) using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br. J. Dermatol. 140:351.
12. Cheng, S. W., M. Kobayashi, A. Tanikawa, K. Kinoshita-Kuroda, M. Amagai, and T. Nishikawa. 2002. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmoglein I and 3. Br. J. Dermatol. 147:261.
13. Futei, Y., M. Amagai, M. Sekiguchi, K. Nishifuji, Y. Fujii, and T. Nishikawa. 2000. Conformational epitope mapping of desmoglein 3 using domain-swapped molecules in pemphigus vulgaris. J. Invest. Dermatol. 115:829.
14. Sekiguchi, M., Y. Futei, Y. Fujii, T. Iwasaki, T. Nishikawa. and M. Amagai. 2001. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J. Immunol. 167:5439.
15. Sugi, T., T. Hashimoto, T. Hibi, and T. Nishikawa. 1989. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation: analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them. J. Clin. Invest. 84:1050.
16. Banchereau, J., P. de Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70.
17. Peyron, E., J. F. Nicolas, A. Reano, P. Roche, J. Thivolet, M. Haftek, D. Schmitt, C. Peronne, J. Banchereau, and F. Rousset. 1994. Human monoclonal autoantibodies specific, for the bullous pemphigoid antigen I (BPAg 1). J. Immunol. 153:1333.
18. Amagai, M., K. Tsunoda, H. Suzuki, K. Nishifuji, S. Koyasu, and T. Nishikawa. 2000. Use of autoantigen knockout mice to develop an active autoimmune disease model of pemphigus. J. Clin. Invest, 105:625.
19. Amagai, M., K. Ishii, A. Takayanagi, T. Nishikawa, and N. Shimizu. 1996. Transport to endoplasmic reticulum by signal peptide, but not proteolytic processing, is required for formation of conformational epitopes of pemphigus vulgaris antigen (Dsg3). J. Invest. Dermatol. 107:539.
20. Amagai, M., S. Karpati, V. Klaus-Kovtun. M. C. Udey, and J. R. Stanley. 1994. The extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion. J. Invest. Dermatol. 102:402.
21. Amagai. M., T. Hashimoto, K. J. Green, N. Shimizu, and T. Nishikawa. 1995. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus, J. Invest. Dermatol. 104:895.
22. Amagai, M., N. Matsuyoshi, Z. H. Wang, C. Andl, and J. R. Stanley, 2000. Toxin in bullous impetigo and staphylococcal scalded skin syndrome targets desmoglein I. Nat. Med. 6:1275.
23. Amagai, M., P. J. Koch, T. Nishikawa, and J. R. Stanley. 1996. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J. Invest. Dermatol. 106:351.
24. Shirakata, Y., M. Amagai, Y. Hanakawa, T. Nishikawa. and K. Hashimoto. 1998. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmogleinl. J. Invest. Dermatol. 110:76.
25. Mahoney, M. G., Z. Wang, K. L. Rothenberger, P. J. Koch, M. Amagai, and J. R. Stanley. 1999. Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J. Clin. Invest. 103:461.
26. Amagai, M. 1999. Autoimmunity against desmosomal cadherins in pemphigus. J. Dermatol. Sci. 20:92.
27. Hanakawa, Y., N. M. Schechter. C. Lin. L. Garza, H. Li, T. Yamaguchi, Y. Fubada, K. Nishifuji, M. Sugai, M. Amagai, and J. R. Stanley. 2002. Molecular mechanisms of blister formation in bullous impegito and staphylococcal scalded skin syndrome. J. Clin. Invest. 110:53.
28. Takeichi, M. 1991. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451.
29. Shapiro, L., A. M. Fannon, P. D. Kwong,. A. Thompson. M. S. Lehmann, G. Grubel, J. F. Legrand. J, Als-Nielsen. D. R. Colman, and W. A. Hendrickson, 1995. Structural basis of cell-cell adhesion by cadherins, Nature 374:327.
30. Nagar, B., M. Overduin, M. Ikura, and J. M. Rini. 1996, Structural basis of calcium-induced E-cadherin rigidification and dimerization. Nature 380:360.
31. Boggon, T. J., J. Murray, S. Chappuis-Flament. E. Wong, B. M. Gumbiner. and L. Shapiro. 2002. C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 296:1308.
32. Ozawa, M., and R. Kemler. 1990. Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin. J, Cell Biol. 111:1645.
33. Kitajima. Y. 1996. Adhesion molecules in the pathophysiology of bullous diseases. Eur. J. Dermatol. 6:399.
34. Aoyama, Y., M. K. Owada. and Y. Kitajima. 1999. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur. J. Immunol. 29:2233.
35. Caldelari, R., A. de Bruin, D. Baumann, M. M. Suter, C. Bierkamp, V. Balmer, and E. Muller. 2001. A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J. Cell Biol. 153:823.
36. Koch, P. J., M. G. Mahoney, H. Ishikawa, L. Pulkkinen, J. Uitto, L. Shultz, G. F. Murphy, D. Whitaker-Menezes, and J. R. Stanley. 1997. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J. Cell Biol. 137:1091.
37. Ohyama, M., M, Amagai, K. Tsunoda, T. Ota, S. Koyasu, A. Umezawa, J. Hata, and T. Nishikawa. 2002. Immunologic and histopathologic characterization of active disease mouse model for pemphigus vulgaris. J. Invest. Dermatol. 118: 199.
38. Memar, O., B. Christensen, S. Rajaraman, R. Goldblum S. K. Tyring, M. M. Brysk, D. J. McCormick, H. Zaim, J. L. Fan, and B. S. Prabhakar. 1996. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3). J. Immunol 157:3171.
39. Fan, J. L., O. Memar. D. J. McCormick, and B. S. Prabhakar. 1999. BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3. J. Immunol. 163:6228.
40. Nguyen, V. T., T. X. Lee, A. Ndoye, L. D. Shultz, M. R. Pittelkow, M. V. Dahl, P. J. Lynch, and S. A. Grando. 1998. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity: development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch. Dermatol. 134:971.
41. Nguyen, V. T., A. Ndoye, and S. A. Grundo. 2000. Pemphigus vulgaris antibody identifies pemphaxin: a novel keratinocyte annexin-like molecule binding acetylcholine. J. Biol. Chem. 275:29466.
42. Nguyen, V. T., A. Ndoye, L. D. Shultz, M. R. Pittelkow, and S. A. Grando. 2000. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J. Clin. Invest. 106:1467.
43. Stanley, J. R., T. Nishikawa, L. A, Diaz, and M. Amagai. 2001. Pemphigus: is there another half of the story? J. Invest. Dermatol. 116:489.